FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHI, H.
Right arrow Articles by ZEMEL, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHI, H.
Right arrow Articles by ZEMEL, M. B.
(The FASEB Journal. 1999;13:1833-1838.)
© 1999 FASEB

Role of the sulfonylurea receptor in regulating human adipocyte metabolism

HANG SHI*, NAIMA MOUSTAID-MOUSSA*, W. O. WILKISON{dagger} and MICHAEL B. ZEMEL*1

* Department of Nutrition, The University of Tennessee, Knoxville, Tennessee 37996, USA; and
{dagger} Zen-Bio, Inc., Research Triangle Park, North Carolina 27709, USA

1Correspondence: University of Tennessee, 1215 West Cumberland Avenue, #229, Knoxville, TN 37996-1900, USA. E-mail: mzemel{at}utk.edu

A regulatory role for intracellular Ca2+ ([Ca2+]i) in adipocyte lipogenesis, lipolysis and triglyceride accumulation has been demonstrated. Compounds acting on the pancreatic sulfonylurea receptor (SUR) to increase (e.g., glibenclamide) or decrease (e.g., diazoxide) [Ca2+]i cause corresponding increases and decreases in weight gain. However, these weight gain and loss effects have been attributed to insulin release rather than to the primary effects of these compounds on the adipocyte SUR and its associated KATP channel. Accordingly, we have evaluated the direct role of the human adipocyte SUR in regulating adipocyte metabolism. We used RT-PCR with primers for a highly conserved region of SUR1 to demonstrate that human adipocytes express SUR1. The PCR product was confirmed by sequence analysis and used as a probe to demonstrate adipocyte SUR1 expression by Northern blot analysis. Adipocytes exhibited glibenclamide dose-responsive (0–20 µM) increases in [Ca2+]i (P<0.05). Similarly, glibenclamide (10 µM) caused a 67% increase in adipocyte fatty acid synthase activity (P<0.001), a 48% increase in glycerol-3-phosphate dehydrogenase activity (P<0.01) and a 68% inhibition in lipolysis (P<0.01), whereas diazoxide (10 µM) completely prevented each of these effects. These data demonstrate that human adipocytes express a SUR that regulates [Ca2+]i and, consequently, exerts coordinate control over lipogenesis and lipolysis. Accordingly, the adipocyte SUR1 may represent an important target for the development of therapeutic interventions in obesity.—Shi, H., Moustaid-Moussa, N., Wilkison, W. O., Zemel, M. B. Role of the sulfonylurea receptor in regulating human adipocyte metabolism.


Key Words: adipocytes • intracellular Ca2+ • fatty acid synthase • SUR




This article has been cited by other articles:


Home page
J BiochemHome page
N. Nakano, N. Miyazawa, T. Sakurai, T. Kizaki, K. Kimoto, K. Takahashi, H. Ishida, M. Takahashi, K. Suzuki, and H. Ohno
Gliclazide Inhibits Proliferation but Stimulates Differentiation of White and Brown Adipocytes
J. Biochem., November 1, 2007; 142(5): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
T. Ren, J. He, H. Jiang, L. Zu, S. Pu, X. Guo, and G. Xu
Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-{alpha} or isoproterenol.
J. Mol. Endocrinol., August 1, 2006; 37(1): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Shi, B. Cave, K. Inouye, C. Bjorbaek, and J. S. Flier
Overexpression of Suppressor of Cytokine Signaling 3 in Adipose Tissue Causes Local but Not Systemic Insulin Resistance
Diabetes, March 1, 2006; 55(3): 699 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. B. Zemel
The Role of Dairy Foods in Weight Management
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 537S - 546S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Sun and M. B. Zemel
Calcium and Dairy Products Inhibit Weight and Fat Regain during Ad Libitum Consumption Following Energy Restriction in Ap2-Agouti Transgenic Mice
J. Nutr., November 1, 2004; 134(11): 3054 - 3060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. B Zemel
Role of calcium and dairy products in energy partitioning and weight management
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 907S - 912S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. B. Zemel
Mechanisms of Dairy Modulation of Adiposity
J. Nutr., January 1, 2003; 133(1): 252S - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ozata, D. Gungor, M. Turan, G. Ozisik, N. Bingol, T. Ozgurtas, and I. C. Ozdemir
Improved Glycemic Control Increases Fasting Plasma Acylation-Stimulating Protein and Decreases Leptin Concentrations in Type II Diabetic Subjects
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3659 - 3664.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. S. Surwit, T. M. Dixon, A. E. Petro, K. W. Daniel, and S. Collins
Diazoxide Restores {beta}3-Adrenergic Receptor Function in Diet-Induced Obesity and Diabetes
Endocrinology, October 1, 2000; 141(10): 3630 - 3637.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. STANDRIDGE, R. ALEMZADEH, M. ZEMEL, J. KOONTZ, and N. MOUSTAID-MOUSSA
Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats
FASEB J, March 1, 2000; 14(3): 455 - 460.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.